Safety and efficacy of high-current tTIS targeting left sgACC for major depressive disorder: A randomized, double-blind, sham-controlled trial. // Cell Reports Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S266637912600529X?dgcid=rss_sd_all
Safety and efficacy of high-current tTIS targeting left sgACC for major depressive disorder: A randomized, double-blind, sham-controlled trial. Cell Reports Medicine. https://www.sciencedirect.com/science/article/pii/S266637912600529X?dgcid=rss_sd_all
“Safety and efficacy of high-current tTIS targeting left sgACC for major depressive disorder: A randomized, double-blind, sham-controlled trial.” Cell Reports Medicine.
@article{article118446,
title = {Safety and efficacy of high-current tTIS targeting left sgACC for major depressive disorder: A randomized, double-blind, sham-controlled trial},
journal = {Cell Reports Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S266637912600529X?dgcid=rss_sd_all}
}